Cibc World Market Inc. Gilead Sciences, Inc. Transaction History

Cibc World Market Inc.

$48 Billion
Q3 2024

A detailed history of Cibc World Market Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cibc World Market Inc. holds 299,664 shares of GILD stock, worth $27 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

299,664

Previous 356,981 16.06%

Holding current value

$27 Million

Previous $24.5 Million 2.58%

% of portfolio

0.05%

Previous 0.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$66.59 - $83.99 $3.82 Million - $4.81 Million	-57,317 Reduced 16.06%	299,664 $25.1 Million
Q2 2024 Aug 07, 2024	BUY	$63.15 - $72.88 $9.95 Million - $11.5 Million	157,609 Added 79.05%	356,981 $24.5 Million
Q1 2024 May 13, 2024	BUY	$71.58 - $87.29 $480,802 - $586,326	6,717 Added 3.49%	199,372 $14.6 Million
Q4 2023 Feb 13, 2024	BUY	$73.27 - $83.09 $18,683 - $21,187	255 Added 0.13%	192,655 $15.6 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $898,223 - $979,979	12,148 Added 6.74%	192,400 $14.4 Million
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $5.85 Million - $6.67 Million	-76,969 Reduced 29.92%	180,252 $13.9 Million
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $75,995 - $86,582	983 Added 0.38%	257,221 $21.3 Million
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $116,850 - $167,756	-1,875 Reduced 0.73%	256,238 $22 Million
Q3 2022 Nov 10, 2022	SELL	$59.54 - $68.01 $391,535 - $447,233	-6,576 Reduced 2.48%	258,113 $15.9 Million
Q2 2022 Aug 10, 2022	SELL	$57.72 - $65.01 $75,324 - $84,838	-1,305 Reduced 0.49%	264,689 $16.4 Million
Q1 2022 May 12, 2022	BUY	$57.92 - $72.58 $1.2 Million - $1.5 Million	20,725 Added 8.45%	265,994 $15.8 Million
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $5 Million - $5.67 Million	-77,044 Reduced 23.9%	245,269 $17.8 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $876,111 - $945,227	12,943 Added 4.18%	322,313 $22.5 Million
Q2 2021 Aug 12, 2021	BUY	$63.47 - $69.35 $2.52 Million - $2.75 Million	39,655 Added 14.7%	309,370 $21.3 Million
Q1 2021 May 11, 2021	SELL	$60.0 - $68.46 $1.17 Million - $1.33 Million	-19,472 Reduced 6.73%	269,715 $17.4 Million
Q4 2020 Feb 08, 2021	SELL	$56.65 - $64.55 $2.72 Million - $3.1 Million	-47,974 Reduced 14.23%	289,187 $16.8 Million
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $709,678 - $892,298	11,428 Added 3.51%	337,161 $21.3 Million
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $1.7 Million - $1.97 Million	23,460 Added 7.76%	325,733 $25.1 Million
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $3.81 Million - $4.88 Million	60,865 Added 25.21%	302,273 $22.6 Million
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $2.21 Million - $2.43 Million	35,920 Added 17.48%	241,408 $15.7 Million
Q3 2019 Nov 13, 2019	BUY	$62.51 - $69.0 $579,592 - $639,768	9,272 Added 4.73%	205,488 $13 Million
Q2 2019 Aug 08, 2019	SELL	$61.87 - $69.38 $570,255 - $639,475	-9,217 Reduced 4.49%	196,216 $13.3 Million
Q1 2019 May 09, 2019	SELL	$62.53 - $70.05 $4.99 Million - $5.59 Million	-79,844 Reduced 27.99%	205,433 $13.4 Million
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $26.8 Million - $35 Million	-443,290 Reduced 60.84%	285,277 $17.8 Million
Q3 2018 Nov 09, 2018	SELL	$71.28 - $78.92 $1.15 Million - $1.28 Million	-16,168 Reduced 2.17%	728,567 $56.3 Million
Q2 2018 Aug 08, 2018	SELL	$64.88 - $75.68 $2.46 Million - $2.86 Million	-37,845 Reduced 4.84%	744,735 $52.8 Million
Q1 2018 May 18, 2018	BUY	$72.84 - $88.8 $9.35 Million - $11.4 Million	128,419 Added 19.63%	782,580 $59 Million
Q4 2017 Feb 01, 2018	BUY	$71.15 - $83.52 $524,944 - $616,210	7,378 Added 1.14%	654,161 $46.9 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $46.6 Million - $55.3 Million	646,783	646,783 $52.4 Million

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Market Inc. with notifications on news.

Account

Cibc World Market Inc. Gilead Sciences, Inc. Transaction History